Hikma Pharmaceuticals (LON:HIK) Stock Price Up 7.4% - Should You Buy?

Hikma Pharmaceuticals PLC (LON:HIK - Get Free Report) shares traded up 7.4% on Friday . The company traded as high as GBX 2,114 ($28.11) and last traded at GBX 2,084 ($27.71). 937,337 shares were traded during trading, a decline of 32% from the average session volume of 1,387,898 shares. The stock had previously closed at GBX 1,941 ($25.81).

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on HIK. Berenberg Bank reissued a "buy" rating and set a GBX 2,560 ($34.04) target price on shares of Hikma Pharmaceuticals in a report on Monday, March 10th. JPMorgan Chase & Co. restated an "overweight" rating on shares of Hikma Pharmaceuticals in a research report on Friday, March 7th.

Hikma Pharmaceuticals Price Performance

The company has a current ratio of 1.66, a quick ratio of 1.27 and a debt-to-equity ratio of 55.82. The business's fifty day moving average price is GBX 1,950.89 and its 200-day moving average price is GBX 2,016.90. The company has a market capitalization of £5.73 billion, a P/E ratio of 20.29, a P/E/G ratio of 2.38 and a beta of 0.41.

Hikma Pharmaceuticals Increases Dividend

The company also recently declared a dividend, which was paid on Thursday, May 1st. Investors of record on Thursday, March 20th were paid a $0.48 dividend. This represents a yield of 1.8%. This is a boost from Hikma Pharmaceuticals's previous dividend of $0.32. The ex-dividend date of this dividend was Thursday, March 20th. Hikma Pharmaceuticals's dividend payout ratio is presently 60.84%.

Insider Activity

In related news, insider Victoria Hull sold 2,777 shares of Hikma Pharmaceuticals stock in a transaction dated Tuesday, April 8th. The stock was sold at an average price of GBX 1,800 ($23.94), for a total value of £49,986 ($66,470.74). Corporate insiders own 30.54% of the company's stock.

About Hikma Pharmaceuticals

At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly.